Allergy, Asthma & Clinical Immunology (Dec 2022)

Physician education on World Asthma Day aids in disease management during the COVID-19

  • Angyang Cao,
  • Yanling Zhou,
  • Wenjun Luo,
  • Dan Lv,
  • Zhonghao Shao,
  • Binbin Zhu,
  • Jianhua Wang

DOI
https://doi.org/10.1186/s13223-022-00741-8
Journal volume & issue
Vol. 18, no. 1
pp. 1 – 7

Abstract

Read online

Abstract Anxiety and depression can negatively affect the management of asthma. The study aimed to assess the psychosocial effects of asthma patients during COVID-19 and analyze potential risk factors and interventions. In June 2022, the “Questionnaire Star” electronic questionnaire system was used to collect data. A total of 98 asthma patients from the affiliated hospital of the medical school of Ningbo University were invited to complete the questionnaires. According to our study, the prevalence of symptoms of anxiety and depression in the asthma patients in the institution was 91.8 and 77.6%, respectively. Patients who had an asthma exacerbation in the previous two months were more likely to have anxiety symptoms (OR = 0.142 95%CI 0.025–0.820), while patients who did not participate in asthma day activities were more likely to have anxiety symptoms than those who did (OR = 0.130 95%CI 0.022–0.762). This study found that routine disease educational lectures on asthma day can successfully alleviate asthma sufferers' anxiety and depression.

Keywords